AGP Limited Stock price

Equities

AGP

PK0113801010

Pharmaceuticals

End-of-day quote Pakistan S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
73.45 PKR +1.73% Intraday chart for AGP Limited +4.44% +4.47%
Sales 2024 * 19.43B 69.95M Sales 2025 * - Capitalization 20.57B 74.04M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.06 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 1,574
Yield 2024 *
5.11%
Yield 2025 *
-
Free-Float 16.07%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.73%
1 week+4.44%
Current month-3.42%
1 month-4.62%
3 months+6.20%
6 months+49.11%
Current year+4.47%
More quotes
1 week
70.06
Extreme 70.06
74.13
1 month
68.50
Extreme 68.5
76.25
Current year
60.21
Extreme 60.21
81.00
1 year
46.00
Extreme 46
81.00
3 years
46.00
Extreme 46
158.99
5 years
46.00
Extreme 46
158.99
10 years
46.00
Extreme 46
158.99
More quotes
Managers TitleAgeSince
Chief Executive Officer - Dec. 31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 21-02-28
Members of the board TitleAgeSince
Director/Board Member - 18-06-06
Chief Executive Officer - Dec. 31
Director/Board Member - 15-11-29
More insiders
Date Price Change Volume
24-03-28 73.45 +1.73% 52,934
24-03-27 72.2 +2.95% 35,062
24-03-26 70.13 -0.24% 28,551
24-03-25 70.3 -0.07% 32,448
24-03-22 70.35 +0.03% 342,697

End-of-day quote Pakistan S.E., March 27, 2024

More quotes
AGP Limited is a Pakistan-based pharmaceutical company. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale, and manufacturing of all kinds of pharmaceutical products. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale, and manufacturing of various kinds of pharmaceutical products. It owns a range of products catering to distinct therapeutic needs of the market. It consists of Holding Company's pharmaceutical segment and related products, and OBS AGP's pharmaceutical segment. It offers a diverse portfolio of products in internal medicine, gynecology, pediatrics, nutraceutical, neuropsychiatry, cardiometabolic, hepatology, and orthopedic. Its products include Afdol, Nebcin, Exotan, Nergab, Febuxin, Zerifax, Protege, Maxna, and Rigix, among others. Its subsidiary includes OBS AGP (Private) Limited (OBS AGP). OBS AGP is in the business of trading pharmaceutical products.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
73.45 PKR
Average target price
100 PKR
Spread / Average Target
+36.15%
Consensus

Chiffre d''affaires - Rate of surprise

  1. Stock
  2. Equities
  3. Stock AGP Limited - Pakistan S.E.